Unicycive Therapeutics, Inc. — DEFA14A Filings
9 DEFA14A filings on record
This page lists all DEFA14A filings submitted to the SEC by Unicycive Therapeutics, Inc. (UNCY), sorted by most recent first. Each row links to the full filing on EdgarLookup. Unicycive Therapeutics, Inc. has filed 9 DEFA14A documents with the SEC since 2019. To view all SEC filings by Unicycive Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
3
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
NT 10-Q
POS AM
PRE 14A
S-1
S-1/A
S-3
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEFA14A | CURRENT REPORT | 0001213900-25-052416 | Jun 9, 2025 | — |
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-25-046551 | May 22, 2025 | — |
| DEFA14A | CURRENT REPORT | 0001213900-25-046246 | May 21, 2025 | — |
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-25-040661 | May 7, 2025 | — |
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-24-040855 | May 8, 2024 | — |
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-24-036720 | Apr 26, 2024 | — |
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-23-048330 | Jun 13, 2023 | — |
| DEFA14A | DEFA14A | 0001213900-23-034012 | May 1, 2023 | — |
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-22-020652 | Apr 20, 2022 | — |